FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Neostigmine Methylsulfate | 5 mg/5 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 3 g/3 L | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 1 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 50 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 300 mg/3000 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 800 ug/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 20 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 25 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 40 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 30 g/3000 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/5 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 100 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ropivacaine Hydrochloride; Clonidine Hydrochloride; Ketorolac Tromethamine; Epinephrine | 123 mg/50 mL; .04 mg/50 mL; 15 mg/50 mL; .25 mg/50 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 140 mg/7 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 60 g/3000 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 100 mg/5 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 200 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 300 g/3000 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.75 g/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 2 g/500 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Diltiazem Hydrochloride | 125 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Droperidol | .625 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Adenosine; Lidocaine Hydrochloride Anhydrous | 39.9 mg/40 mL; 40 mg/40 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Heparin Sodium | 20 U/20 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Heparin Sodium | 50 U/50 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone Hydrochloride | 900 mg/500 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Amiodarone Hydrochloride | 450 mg/250 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Labetalol Hydrochloride | 20 mg/4 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine Hydrochloride | 100 mg/5 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine Hydrochloride | 91 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine Hydrochloride | 9.1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine Hydrochloride | 100 mg/10 mL | 2020-2 | source_no_ndc | 2026-11-12 |